VEITHsymposium™

Program (November 2024)

The program features over 1,300 rapid-fire presentations offered in more than 100 sessions throughout the five-day event. Click on the day below to review the sessions, then click on the session number to see a listing of presentations and speakers within a session.

View/Print Entire November 2024 Program

Program Outline at a Glance

TUESDAY PROGRAMS
Program A:	PROGRAM A (SESSIONS 1-8) - 7:02 A.M. - 6:02 P.M. (9.75 CME CREDIT HOURS) PROGRESS IN THE TREATMENT OF DISEASES OF THE HEART VALVES AND THE THORACIC AND ABDOMINAL AORTA
Location:	Grand Ballroom East, 3rd Floor

Program B:	PROGRAM B (SESSIONS 9-16) – 6:47 A.M. - 5:59 P.M. (9.5 CME CREDIT HOURS) PROGRESS IN WEARABLE REMOTE MEASUREMENT DEVICES, VASCULAR ROBOTICS, GUIDANCE SYSTEMS, LAPAROSCOPY, SIMULATION AND COVID; NEW DEVELOPMENTS IN CAROTID DISEASE AND ACUTE STROKE TREATMENT; ABDOMINAL AORTIC BRANCH TREATMENT; NEW TECHNOLOGY CONCEPTS AND ARTIFICIAL INTELLIGENCE (AI); VASCULAR SURGERY IDENTITY, TRAINING, MANPOWER AND MENTORSHIP; UPDATES ON OPEN VASCULAR SURGERY AND TREATMENT OF AORTIC COARCTATION
Location:	Grand Ballroom West, 3rd Floor

Program C-1:	PROGRAM C-1 (SESSIONS 17-18) – 7:00 A.M. - 12:00 P.M. (4.5 CME CREDIT HOURS) MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH Course Leader: Michael R. Jaff, DO
Location:	Trianon Ballroom, 3rd Floor

Program C-2:	PROGRAM C-2 (SESSIONS 19-22) – 1:00 P.M. - 6:06 P.M. (4.75 CME CREDITS HOURS) INTERESTING TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENTS
Location:	Trianon Ballroom, 3rd Floor

WEDNESDAY PROGRAMS
Program D:	PROGRAM D (SESSIONS 23-30) – 6:40 A.M. - 6:05 P.M. (10.5 CME CREDIT HOURS) PROGRESS IN LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENT
Location:	Grand Ballroom East, 3rd Floor

Program E:	PROGRAM E (SESSIONS 31-38) – 6:40 A.M. - 6:05 P.M. (10.25 CME CREDIT HOURS) NEW DEVELOPMENTS IN MEDICAL TREATMENTS AND NEW DRUGS; PROGRESS IN ANTI-ATHEROGENIC AND ANTI-HYPERTENSIVE TREATMENTS; MANAGEMENT OF ENDOLEAKS; RECORDED LIVE CASES FROM LEADING CENTERS IN THE US AND EU; ISSUES OF INTEREST; OUTPATIENT AND OFFICE BASED VASCULAR TREATMENT; TOPICS RELATED TO GOVERNMENT, REIMBURSEMENT, THE SVS, VQI, FDA, GUIDELINES, TRIALS AND EVIDENCE BASED MEDICINE
Location:	Grand Ballroom West, 3rd Floor

Program F:	PROGRAM F (SESSIONS 39-46) – 6:50 A.M. - 6:10 P.M. (10 CME CREDIT HOURS) MORE NEW DEVELOPMENTS IN THORACIC AORTIC DISEASE, TEVAR, AORTIC DISSECTIONS, TAAAs, JUXTA- AND PARARENAL AAAs, PARALLEL GRAFTS, FENESTRATED AND BRANCHED EVAR (F/B/EVAR), MULTILAYER BARE STENTS, INFRARENAL AAAs AND STANDARD EVAR, AND HOT NEW AORTIC TOPICS
Location:	Trianon Ballroom, 3rd Floor

THURSDAY PROGRAMS
Program G:	PROGRAM G (SESSIONS 47-54) – 6:56 A.M. - 6:00 P.M. (9.75 CME CREDIT HOURS) EXCITING NEW OR REDISCOVERED TECHNIQUES, CONCEPTS OR DEVICES; PROGRESS IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs; TRIBUTE TO OUR MILITARY; PROGRESS IN THE TREATMENT OF RUPTURED AAAs; MORE ABOUT NEW DEVICES, TECHNIQUES OR CONCEPTS; PROGRESS IN RADIATION SAFETY
Location:	Grand Ballroom East, 3rd Floor

Program H:	PROGRAM H (SESSIONS 55-63) – 7:00 A.M. - 5:59 P.M. (9.5 CME CREDIT HOURS) NEW OR IMPROVED DEVICES FOR: STANDARD EVAR AND MORE COMPLEX AAAs; REPAIRS OF TAAAs, THE ASCENDING AORTA, THE AORTIC ARCH, AND THE DESCENDING AORTA (TEVAR); NEW DEVICES FOR TREATING LOWER EXTREMITY LESIONS BY ENDO OR OPEN TECHNIQUES; UPDATE ON ENDOANCHORS AND FIXATION DEVICES AND NEW OR IMPROVED DEVICES FOR ENDOVASCULARLY REMOVING CLOT AND OCCLUDING BLOOD VESSELS
Location:	Grand Ballroom West, 3rd Floor

Program I:	PROGRAM I (SESSIONS 64-73) – 7:00 A.M. - 7:00 P.M. (11 CME CREDIT HOURS) SUPERFICIAL VENOUS DISEASE Course Leaders: Jose I. Almeida, MD, Lowell S. Kabnick, MD, Peter Gloviczki, MD, Thomas W. Wakefield, MD and Steve Elias, MD
Location:	Trianon Ballroom, 3rd Floor

Program J:	PROGRAM J (SESSIONS 74-78) – 7:30 A.M. - 12:15 P.M. (4.75 CME CREDIT HOURS) MULTIDISCIPLINARY STROKE PREVENTION AND TREATMENT Course Leader: Allan L. Brook, MD
Location:	Murray Hill Suites, 2nd Floor

FRIDAY PROGRAMS
Program K:	PROGRAM K (SESSIONS 79-86) – 6:40 A.M. - 5:32 P.M. (9.75 CME CREDIT HOURS) PROGRESS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) WITH TAAAs AND COMPLEX AORTIC ANEURYSM REPAIRS; NEW DEVELOPMENTS IN CAROTID ARTERY DISEASE AND ITS TREATMENT: MESH COVERED STENTS AND TCAR, COGNITIVE CHANGES, TIMING OF TREATMENT, MEDICAL TREATMENT, UPDATE ON CAROTID TRIALS, TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS), STRING SIGN, CAROTID CLOT, SIGNIFICANCE OF MRI LESIONS, CAROTID CONTROVERSIES AND MORE CAROTID TOPICS; OTHER NEW ENDOVASCULAR TREATMENT CONCEPTS, TECHNIQUES; UPDATE ON PERCUTANEOUS ACCESS CLOSURE DEVICES AND WOUND CARE
Location:	Grand Ballroom East, 3rd Floor

Program L:	PROGRAM L (SESSIONS 87-94) – 6:52 A.M. - 4:56 P.M. (8.75 CME CREDIT HOURS) NEW DEVELOPMENTS IN THE TREATMENT OF POPLITEAL DISEASE; ADVANCES IN TREATING ARTERIAL AND GRAFT INFECTIONS; ADVANCES IN VASCULAR IMAGING AND GUIDANCE; AUGMENTED REALITY AND ARTIFICIAL INTELLIGENCE; RECORDED LIVE COMPLEX ENDOVASCULAR CASES FROM MÜNSTER, GERMANY; NEW DEVELOPMENTS IN THORACIC OUTLET SYNDROME MANAGEMENT; ADVANCES IN MEDICAL, DRUG, ANTICOAGULANT AND RARE VASCULAR DISEASE TREATMENT; AND ADVANCES IN THE TREATMENT OF VASCULAR TRAUMA
Location:	Grand Ballroom West, 3rd Floor

Program M:	PROGRAM M (SESSIONS 95-105) – 7:30 A.M. - 6:45 P.M. (9.25 CME CREDIT HOURS) DEEP VENOUS DISEASE Jose I. Almeida, MD, Lowell S. Kabnick, MD, Peter Gloviczki, MD, Thomas W. Wakefield, MD and Steve Elias, MD
Location:	Trianon Ballroom, 3rd Floor

SATURDAY PROGRAMS
Program N:	PROGRAM N (SESSIONS 106-109) – 7:00 A.M. - 12:06 P.M. (5 CME CREDIT HOURS) TOPICS TOO IMPORTANT TO MISS IN GENERAL AND IN THE TREATMENT OF LOWER EXTREMITY, AORTIC OR CAROTID DISEASE
Location:	Grand Ballroom East, 3rd Floor

Program O:	PROGRAM O (SESSIONS 110-115) – 8:00 A.M. - 4:00 P.M. (6.5 CME CREDIT HOURS) IMPROVING OUTCOMES IN HEMODIALYSIS ACCESS Course Leaders: Larry A. Scher, MD, Anton N. Sidawy, MD, and Haimanot (Monnie) Wasse, MD, MPH
Location:	Grand Ballroom West, 3rd Floor

Program P:	PROGRAM P (SESSIONS 116-125) – 6:50 A.M. - 5:35 P.M. (9.75 CME CREDIT HOURS) ADVANCES IN VASCULAR IMAGING AND DIAGNOSIS Course Leaders: George L. Berdejo, BA, RVT and Natalie A. Marks, MD, RPVI, RVT
Location:	Murray Hill Suites, 2nd Floor

Tuesday, November 19, 2024 - Program Details

Open All Tuesday Sessions

COMBINED PROGRAM FOR VASCULAR SURGERY, INTERVENTIONAL RADIOLOGY, CARDIOLOGY AND CARDIOTHORACIC SURGERY

6:00 AM - General Registration - New York Hilton Midtown
                 Rhinelander Gallery, 2nd Floor
6:00 AM - Faculty Registration - New York Hilton Midtown
                 Gramercy Suite West, 2nd Floor
6:15 AM - Continental Breakfast - New York Hilton Midtown
                 Rhinelander Gallery, 2nd Floor

PROGRAMS A, B AND C ARE CONCURRENT TUESDAY PROGRAMS
PROGRAM A (SESSIONS 1-8 - PROGRESS IN THE TREATMENT OF DISEASES OF THE HEART VALVES AND THE THORACIC AND ABDOMINAL AORTA; 7:02 A.M. to 6:02 P.M.) Location: Grand Ballroom East, 3rd Floor
SESSION 1:	PROGRESS IN TRANSCATHETER VALVE REPLACEMENT AND TREATMENT OF ASCENDING AORTIC DISEASE
SESSION 2:	PROGRESS IN THE TREATMENT OF AORTIC ARCH LESIONS AND AORTIC DISSECTIONS
SESSION 3:	PROGRESS IN THE ENDOVASCULAR TREATMENT OF THE ASCENDING AORTA, AORTIC ARCH, AORTIC DISSECTIONS, REPORTING STANDARDS AND CLASSIFICATION SYSTEMS, STABILISE, GUIDELINES AND MORE
SESSION 4:	MORE NEW DEVELOPMENTS IN THE TREATMENT OF TBADs, THORACIC AORTIC DISEASE AND THORACOABDOMINAL ANEURYSMS (TAAAs)
SESSION 5:	NEW DEVELOPMENTS IN ABDOMINAL AORTIC ANEURYSM (AAA) ETIOLOGY, DETECTION, TREATMENT AND EVAR
SESSION 6:	MORE ABOUT TBADs, AAAs AND EVAR, STANDARD AND COMPLEX: UPDATES ON PHYSICIAN MODIFIED ENDOGRAFTS (PMEGs) AND GUIDELINES
SESSION 7:	MORE NEW DEVELOPMENTS IN THE TREATMENT OF THORACIC AORTIC PATHOLOGY
SESSION 8:	MORE NEW DEVELOPMENTS REGARDING TBADs AND TEVAR: NEED FOR AND TIMING OF TEVAR FOR ACUTE UNCOMPLICATED TYPE B AORTIC DISSECTION (uTBADs) (FOR IMPORTANT RELATED TALKS SEE SESSION 8 IN OUR 2023 PROGRAM ON OUR WEBSITE VEITHsymposium.org)
PROGRAM B (SESSIONS 9-16 - PROGRESS IN WEARABLE REMOTE MEASUREMENT DEVICES, VASCULAR ROBOTICS, GUIDANCE SYSTEMS, LAPAROSCOPY, SIMULATION AND COVID; NEW DEVELOPMENTS IN CAROTID DISEASE AND ACUTE STROKE TREATMENT; ABDOMINAL AORTIC BRANCH TREATMENT; NEW TECHNOLOGY CONCEPTS AND ARTIFICIAL INTELLIGENCE (AI); VASCULAR SURGERY IDENTITY, TRAINING, MANPOWER AND MENTORSHIP; UPDATES ON OPEN VASCULAR SURGERY, AND TREATMENT OF AORTIC COARCTATION; 6:47 A.M. to 5:59 P.M.) Location: Grand Ballroom West, 3rd Floor
SESSION 9:	PROGRESS IN WEARABLE VASCULAR ROBOTICS, LAPAROSCOPY, GUIDANCE SYSTEMS AND SIMULATION
SESSION 10:	NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT; DIFFERING VIEWS ON TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS) AND CAROTID SCREENING
SESSION 11:	MORE ABOUT CAROTID DISEASE: UPDATE ON INVASIVE TREATMENT FOR ACUTE STROKES
SESSION 12:	PROGRESS IN THE TREATMENT OF AORTIC AND AORTOILIAC OCCLUSIVE DISEASE; HYPOGASTRIC REVASCULARIZATION
SESSION 13:	NEW CONCEPTS; MACHINE LEARNING AND ARTIFICIAL INTELLIGENCE (AI); TO DECREASE RADIATION (SEE ALSO SESSIONS 9 AND 90)
SESSION 14:	ISSUES IMPORTANT TO VASCULAR SURGERY'S INDEPENDENCE, IDENTITY AND TRAINING; SHOULD WE GET A COVID-19 VACCINATION
SESSION 15:	PROGRESS IN THE TREATMENT OF VISCERAL AND RENAL ARTERY DISEASE (FOR IMPORTANT RELATED TALKS SEE SESSION 15 IN OUR 2023 PROGRAM ON OUR WEBSITE VEITHsymposium.org)
SESSION 16:	UPDATE ON OPEN VASCULAR SURGICAL PROCEDURES; PROGRESS IN THE TREATMENT OF AORTIC COARCTATIONS (FOR IMPORTANT RELATED TALKS SEE SESSION 16 IN OUR 2023 PROGRAM ON OUR WEBSITE VEITHsymposium.org)
PROGRAM C-1 (SESSIONS 17-18 - MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH; 7:00 A.M. to 12:00 P.M.) Location: Trianon Ballroom, 3rd Floor
SESSION 17:	MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH - PART 1
SESSION 18:	MANAGEMENT OF PULMONARY EMBOLISM: THE ULTIMATE APPROACH – PART 2
PROGRAM C-2 (SESSIONS 19-22 - INTERESTING TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENTS; 1:00 P.M. to 6:06 P.M.) Location: Trianon Ballroom, 3rd Floor
SESSION 19:	HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENTS - MEDICAL AND NATURAL HISTORY ISSUES
SESSION 20:	MORE HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENT – EVALUATING ARTERIAL ANATOMY AND TREATMENT OUTCOMES WITH CLTI
SESSION 21:	HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENTS
SESSION 22:	MORE HOT NEW TOPICS RELATED TO LOWER EXTREMITY OCCLUSIVE DISEASE, CLTI AND ITS TREATMENTS

Wednesday, November 20, 2024 - Program Details

Open All Wednesday Sessions

PROGRAMS D, E AND F ARE CONCURRENT WEDNESDAY PROGRAMS
PROGRAM D (SESSIONS 23-30 - PROGRESS IN LOWER EXTREMITY OCCLUSIVE DISEASE AND ITS TREATMENT; 6:40 A.M. to 6:05 P.M.) Location: Grand Ballroom East, 3rd Floor
SESSION 23:	GENERALITIES IN THE ENDOVASCULAR AND OPEN TREATMENT OF LOWER EXTREMITY OCCLUSIVE DISEASE AND CLTI
SESSION 24:	NEW DEVELOPMENTS IN ATHERECTOMY, STENTS (UNCOATED, COATED AND BIORESORBABLE)
SESSION 25:	LOWER EXTREMITY TOPICS RELATED TO DRUG COATED BALLOONS (DCBs), AND DRUG ELUTING STENTS (DESs) AND OTHER INTERWOVEN (SUPERA) STENTS
SESSION 26:	NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTs) AND BTK LESION TREATMENTS WITH DCBs AND DESs
SESSION 27:	PROGRESS IN EXOTIC AND EXTREME NEW TREATMENTS FOR VERY DISTAL LOWER EXTREMITY DISEASE CAUSING ADVANCED CLTI: OPTIONS TO SAVE THE “NO OPTION FOR TREATMENT” LIMB AND THE “DESERT FOOT”
SESSION 28:	NEW DEVELOPMENTS IN PROSTHETIC GRAFTS; STENT-GRAFTS; PERCUTANEOUS ENDOVASCULAR BYPASSES; STENT OCCLUSIONS AND TREATMENT OF IN STENT RESTENOSIS (ISR)
SESSION 29:	LOWER EXTREMITY TRIALS; GUIDELINES; FOOT PERFUSION EVALUATION METHODS AND VALUE OF ANGIOSOMES
SESSION 30:	NEW DEVELOPMENTS IN THE TREATMENT OF INTERMITTENT CLAUDICATION (IC) AND ACUTE LIMB ISCHEMIA (ALI)
PROGRAM E (SESSIONS 31-38 - NEW DEVELOPMENTS IN MEDICAL TREATMENTS AND NEW DRUGS; PROGRESS IN ANTI-ATHEROGENIC AND ANTI-HYPERTENSIVE TREATMENTS; MANAGEMENT OF ENDOLEAKS; RECORDED LIVE CASES FROM LEADING CENTERS IN THE US AND EU; ISSUES OF INTEREST; OUTPATIENT AND OFFICE BASED VASCULAR TREATMENT; TOPICS RELATED TO GOVERNMENT, REIMBURSEMENT, THE SVS, VQI, FDA, GUIDELINES, TRIALS AND EVIDENCE BASED MEDICINE; 6:40 A.M. to 6:05 P.M.) Location: Grand Ballroom West, 3rd Floor
SESSION 31:	ADVANCES IN MEDICAL DIAGNOSIS AND TREATMENTS IN VASCULAR PATIENTS; NEW ANTI-ATHEROGENIC DRUGS AND RIVAROXABAN
SESSION 32:	CATHETER BASED TREATMENTS FOR RESISTANT HYPERTENSION; MANAGEMENT OF CARDIAC PROBLEMS, CORONARY DESs, SMOKING AND TRANSFUSION IN VASCULAR SURGERY PATIENTS; PREVENTING VASCULAR AND CARDIAC COMPLICATIONS
SESSION 33:	PROGRESS IN MANAGING ENDOLEAKS: UNDERSTANDING THEIR CONSEQUENCES AND PREDICTING, PREVENTING AND TREATING THEM (FOR IMPORTANT RELATED TALKS SEE SESSION 33 IN OUR 2023 PROGRAM ON OUR WEBSITE VEITHsymposium.org)
SESSION 34:	ISSUES IMPORTANT TO VASCULAR SURGEONS/SPECIALISTS
SESSION 35:	RECORDED LIVE CHALLENGING CASES AND INNOVATIVE TECHNIQUES FROM THE PLINIO ROSSI AND LINC COMPONENTS
SESSION 36:	MORE ISSUES IMPORTANT IN VASCULAR SURGERY: HISTORY, PRACTICE PATTERNS, VALUE OF GUIDELINES AND RCTs, MALPRACTICE, SCIENCE, TRAINING AND HUMAN BEHAVIOR
SESSION 37:	MORE ISSUE-RELATED TOPICS IMPORTANT TO VASCULAR SURGEONS AND VASCULAR SPECIALISTS; ISSUES RELATED TO OUTPATIENT CENTERS OR OFFICE BASED LABS (OBLs)
SESSION 38:	UPDATES AND ISSUES IMPORTANT TO ALL VASCULAR SURGEONS AND SPECIALISTS: FUTURE REIMBURSEMENT; IMPROVING VASCULAR CARE QUALITY; FIXING FALSE TESTIMONY; FLAWED PEER REVIEW; FDA IMPROVEMENTS; LEARNING HEALTH SYSTEMS
PROGRAM F (SESSIONS 39-46 - MORE NEW DEVELOPMENTS IN THORACIC AORTIC DISEASE, TEVAR, AORTIC DISSECTIONS, TAAAs, JUXTA- AND PARARENAL AAAs, PARALLEL GRAFTS, FENESTRATED AND BRANCHED EVAR (F/B/EVAR), MULTILAYER BARE STENTS, INFRARENAL AAAs AND STANDARD EVAR, AND HOT NEW AORTIC TOPICS; 6:50 A.M. to 6:10 P.M.) Location: Trianon Ballroom, 3rd Floor
SESSION 39:	MORE TOPICS RELATED TO THE THORACIC AORTA, AORTIC DISSECTIONS, INFLAMMATORY ANEURYSMS AND THEIR TREATMENT
SESSION 40:	MORE ADVANCES RELATED TO TREATING PATHOLOGY INVOLVING THE ASCENDING AORTA AND THE AORTIC ARCH; AORTIC DISSECTIONS, INTRAMURAL HEMATOMAS (IMHs) AND THEIR TREATMENT
SESSION 41:	OPEN AND ENDO TREATMENT OF COMPLEX AAAs (JUXTA, PARA- AND SUPRA-RENAL) AND TAAAs; INTERESTING NEW DEVICES FOR THEIR TREATMENT
SESSION 42:	PROGRESS IN TREATING ILIAC ANEURYSMS; ILIAC BRANCHED DEVICES (IBDs); UPDATE ON MULTILAYER FLOW MODULATING (MLFM) AND OTHER BARE STENTS FOR TREATING ANEURYSMS AND DISSECTIONS
SESSION 43:	MORE NEW DEVELOPMENTS IN AAA TREATMENT AND STANDARD EVAR: A NEW DEVICE TO SLOW AAA GROWTH; AAA NECK DILATATION AFTER EVAR; VALUE OF LOW PROFILE AAA ENDOGRAFTS; IMPROVED ULTRASOUND SURVEILLANCE AND ALL AAAs ARE NOT TIME BOMBS WAITING TO EXPLODE
SESSION 44:	MORE NEW DEVELOPMENTS IN AAAs: WITH HERITABLE AORTIC DISEASE (CONNECTIVE TISSUE GENETIC DISORDERS): HOW DOES THROMBUS LOAD EFFECT PROGNOSIS AFTER EVAR; OTHER RELATED AAA TOPICS
SESSION 45:	MORE HOT AORTIC TOPICS
SESSION 46:	MORE SHORT HOT NEW TOPICS RELATED TO AORTC DISEASE AND ITS TREATMENT

Thursday, November 21, 2024 - Program Details

Open All Thursday Sessions

PROGRAMS G, H, I AND J ARE CONCURRENT THURSDAY PROGRAMS
PROGRAM G (SESSIONS 47-54 - EXCITING NEW OR REDISCOVERED TECHNIQUES, CONCEPTS OR DEVICES; PROGRESS IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs; TRIBUTE TO OUR MILITARY; PROGRESS IN THE TREATMENT OF RUPTURED AAAs; MORE ABOUT NEW DEVICES, TECHNIQUES OR CONCEPTS; PROGRESS IN RADIATION SAFETY; 6:56 A.M. to 6:00 P.M.) Location: Grand Ballroom East, 3rd Floor
SESSION 47:	EXCITING NEW OR REDISCOVERED TECHNIQUES, DEVICES, CONCEPTS
SESSION 48:	PROGRESS IN FENESTRATED AND BRANCHED EVAR (F/B/EVAR) AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS
SESSION 49:	MORE PROGRESS IN F/B/EVAR AND PARALLEL GRAFTS FOR COMPLEX AAAs AND TAAAs; AND RELATED TOPICS
SESSION 50:	A TRIBUTE TO OUR MILITARY AND MILITARY PHYSICIANS: SOME MILITARY HISTORY; TREATMENT OF MILITARY AND CIVILIAN VASCULAR INJURIES AND CONTROL OF HEMORRHAGE; UPDATE ON REBOA
SESSION 51:	PROGRESS IN THE TREATMENT OF RUPTURED INFRARENAL AAAs, COMPLEX AAAs, TAAAs AND RELATED TOPICS
SESSION 52:	MORE NEW DEVELOPMENTS IN TECHNIQUES OF ENDO TREATMENT OF RUPTURED AAAs, COMPLEX AAAs AND TAAAs; WHAT IS AND SHOULD BE HAPPENING WITH AAA SCREENING
SESSION 53:	EXCITING NEW OR UPDATED CONCEPTS, TECHNIQUES AND TREATMENTS
SESSION 54:	PROGRESS IN RADIATION SAFETY AND MORE NEW CONCEPTS, DEVICES AND TECHNIQUES
PROGRAM H (SESSIONS 55-63 - NEW OR IMPROVED DEVICES FOR: STANDARD EVAR AND MORE COMPLEX AAAs; REPAIRS OF TAAAs, THE ASCENDING AORTA, THE AORTIC ARCH, AND THE DESCENDING AORTA (TEVAR); NEW DEVICES FOR TREATING LOWER EXTREMITY LESIONS BY ENDO OR OPEN TECHNIQUES; UPDATE ON ENDOANCHORS AND FIXATION DEVICES AND NEW OR IMPROVED DEVICES FOR ENDOVASCULARLY REMOVING CLOT AND OCCLUDING BLOOD VESSELS; 7:00 A.M. to 5:59 P.M.) Location: Grand Ballroom West, 3rd Floor
SESSION 55:	NEW OR IMPROVED DEVICES FOR INFRARENAL AAA REPAIR WITH STANDARD EVAR
SESSION 56:	NEW OR UPDATED DEVICES FOR STANDARD EVAR OR F/B/EVAR
SESSION 57:	NEW OR IMPROVED DEVICES FOR THORACOABDOMINAL ANEURYSM (TAAA) REPAIRS AND THORACIC AORTIC LESION REPAIRS (TEVAR)
SESSION 58:	NEW OR IMPROVED DEVICES FOR THE ASCENDING AORTA, THE AORTIC ARCH OR NEAR THE ARCH AND TAAAs (SEE ALSO SESSIONS 1, 2, 3 AND 40 FOR RELATED TOPICS)
SESSION 59:	NEW OR UPDATED INFORMATION ON RE-ENTRY DEVICES, LOWER EXTREMITY PROSTHETIC GRAFTS (SEE ALSO SESSION 28) AND MANAGEMENT OF PERIGRAFT SEROMAS
SESSION 60:	NEW OR IMPROVED ENDOVASCULAR DEVICES FOR LOWER EXTREMITY TREATMENTS: ATHERECTOMY, STENTS, ACCESSORIES, ETC. (SEE ALSO SESSIONS 23-27)
SESSION 61:	NEW OR IMPROVED ENDOVASCULAR DEVICE COMBINATIONS FOR LOWER EXTREMITY TREATMENTS: ANGIOPLASTY BALLOON IMPROVEMENTS
SESSION 62:	NEW OR IMPROVED DEVICES AND TECHNIQUES TO PREVENT OR TREAT ENDOLEAKS OR DEVICE MIGRATION: ENDOANCHORS, ETC.
SESSION 63:	NEW OR IMPROVED ENDOVASCULAR DEVICES FOR CLOT REMOVAL OR EMBOLIZATION (SEE ALSO SESSION 30)
PROGRAM I (SESSIONS 64-73 - SUPERFICIAL VENOUS DISEASE; 7:00 A.M. to 7:00 P.M.) Location: Trianon Ballroom, 3rd Floor
SESSION 64:	VENOUS CLINICAL EXAMINATION AND HEMODYNAMICS
SESSION 65:	VENOUS GUIDELINES, IMPORTANT PAPERS, AND REIMBURSEMENT
SESSION 66:	SUPERFICIAL VEIN TREATMENT STRATEGIES I
SESSION 67:	SUPERFICIAL VEIN TREATMENT STRATEGIES II
SESSION 68:	SUPERFICIAL VEIN TREATMENT STRATEGIES III
SESSION 69:	SUPERFICIAL VEIN TREATMENT STRATEGIES IV
SESSION 70:	SUPERFICIAL VEIN TREATMENT STRATEGIES V
SESSION 71:	SUPERFICIAL VEIN TREATMENT STRATEGIES VI
SESSION 72:	LIPEDEMA, LYMPHEDEMA, PHLEBOLYMPHEDEMA
SESSION 73:	VENOUS ULCERS
PROGRAM J (SESSIONS 74-78 - MULTIDISCIPLINARY STROKE PREVENTION AND TREATMENT) Location: Murray Hill Suites, 2nd Floor
SESSION 74:	ADVANCES IN STROKE AND THE NEXT FRONTIER
SESSION 75:	INTRACRANIAL HEMORRHAGE, VESSEL WALL IMAGING AND NEW DEVELOPMENTS
SESSION 76:	CAROTID AND CEREBRAL ANEURYSMS LATER TRENDS AND POTPOURRI
SESSION 77:	PEDIATRIC STROKE AND LESSONS TO BE LEARNED IN UNIQUE CEREBROVASCULAR ARENAS
SESSION 78:	CAROTID ARTERY THERAPY STARS AND LATEST TRENDS

Friday, November 22, 2024 - Program Details

Open All Friday Sessions

PROGRAMS K, L AND M ARE CONCURRENT FRIDAY PROGRAMS
PROGRAM K (SESSIONS 79-86 - PROGRESS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) WITH TAAAs AND COMPLEX AORTIC ANEURYSM REPAIRS; NEW DEVELOPMENTS IN CAROTID ARTERY DISEASE AND ITS TREATMENT: MESH COVERED STENTS AND TCAR, COGNITIVE CHANGES, TIMING OF TREATMENT, MEDICAL TREATMENT, UPDATE ON CAROTID TRIALS, TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS), STRING SIGN, CAROTID CLOT, SIGNIFICANCE OF MRI LESIONS, CAROTID CONTROVERSIES AND MORE CAROTID TOPICS; OTHER NEW ENDOVASCULAR TREATMENT CONCEPTS, TECHNIQUES; UPDATE ON PERCUTANEOUS ACCESS CLOSURE DEVICES AND WOUND CARE; 6:40 A.M. to 5:32 P.M.) Location: Grand Ballroom East, 3rd Floor
SESSION 79:	PROGRESS IN THE PREVENTION AND TREATMENT OF SPINAL CORD ISCHEMIA (SCI) ASSOCIATED WITH THE TREATMENT OF THORACIC, THORACOABDOMINAL AND COMPLEX ABDOMINAL ANEURYSMS
SESSION 80:	NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS: UPDATE ON MESH COVERED STENTS AND TCAR (TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION)
SESSION 81:	MORE CAROTID HOT TOPICS RELATED TO TCAR, CAS AND EFFECTS OF INTERVENTIONS ON COGNITIVE FUNCTION
SESSION 82:	MORE CAROTID RELATED NEW DEVELOPMENT TOPICS RELATED TO TCAR, CAS AND CEA, NEW DEVICES, MESH COVERED STENTS, MINI-INCISION CEA, SIGNIFICANCE OF DW MRI DEFECTS, TIMING OF TREATMENT, MEDICAL TREATMENT AND DEALING WITH DISTAL (HIGH) CAROTID LESIONS
SESSION 83:	MORE HOT CAROTID AND SUBCLAVIAN TOPICS: UPDATES ON KEY CAROTID RCTs
SESSION 84:	MORE HOT CAROTID TOPICS: TREATMENT IN 2024 OF RECURRENT CAROTID STENOSIS; STROKES DURING CAROTID TREATMENT; CAROTID NEAR OCCLUSIONS; SILENT CORONARY ISCHEMIA IN CAROTID PATIENTS
SESSION 85:	UPDATED ENDOVASCULAR CONCEPT AND MORE HOT AND CONTROVERSIAL CAROTID TOPICS
SESSION 86:	NEW CONCEPTS AND NEW DEVELOPMENTS IN PERCUTANEOUS ACCESS CLOSURE AND WOUND CARE
PROGRAM L (SESSIONS 87-94 - NEW DEVELOPMENTS IN THE TREATMENT OF POPLITEAL DISEASE; ADVANCES IN TREATING ARTERIAL AND GRAFT INFECTIONS; ADVANCES IN VASCULAR IMAGING AND GUIDANCE; AUGMENTED REALITY AND ARTIFICIAL INTELLIGENCE; RECORDED LIVE COMPLEX ENDOVASCULAR CASES FROM MÜNSTER, GERMANY; NEW DEVELOPMENTS IN THORACIC OUTLET SYNDROME MANAGEMENT; ADVANCES IN MEDICAL, DRUG, ANTICOAGULANT AND RARE VASCULAR DISEASE TREATMENT; AND ADVANCES IN THE TREATMENT OF VASCULAR TRAUMA; 6:52 A.M. to 4:56 P.M.) Location: Grand Ballroom West, 3rd Floor
SESSION 87:	POPLITEAL DISEASE TOPICS RELATED TO ANEURYSM TREATMENT, ENTRAPMENTS, ADVENTITIAL CYSTIC DISEASE AND TRAUMA
SESSION 88:	NEW DEVELOPMENTS IN TREATING ARTERIAL (INCLUDING AORTIC) GRAFT INFECTIONS
SESSION 89:	PROGRESS IN VASCULAR IMAGING AND GUIDANCE FOR ENDOVASCULAR TREATMENTS WITH LESS RADIATION EXPOSURE OR CONTRAST TOXICITY
SESSION 90:	ARTIFICIAL INTELLIGENCE WORKFLOWS IN AORTIC CARE: HOW TO DO THE MOST COMPLEX AORTIC CASES BY EXPERTS IN THE FIELD
SESSION 91:	PRESENTATIONS AND CHALLENGING RECORDED LIVE CASES FROM MÜNSTER, GERMANY
SESSION 92:	NEW DEVELOPMENTS IN THE TREATMENT OF THORACIC OUTLET SYNDROMES (TOSs)
SESSION 93:	BEST ANTIPLATELET REGIMENS UPDATE ON RARE VASCULAR DISEASES; NEW DEVELOPMENTS IN ANTIPLATELET AND ANTICOAGULATION REGIMENS AND MEDICAL AND DRUG TREATMENTS
SESSION 94:	ADVANCES IN THE ENDO AND OPEN TREATMENT OF VASCULAR TRAUMA
COMBINED VEITHsymposium and AVIDsymposium SESSIONS
VEITHsymposium PROGRAM M (SESSIONS 95-105 - DEEP VENOUS DISEASE; 7:30 A.M. to 6:45 P.M.) Location: Trianon Ballroom, 3rd Floor
SESSION 95:	DEEP VENOUS PHYSIOLOGY AND VENOUS STENT ISSUES
SESSION 96:	VENOUS STENT TRIALS
SESSION 97:	FEMORO-ILIOCAVAL CHRONIC TOTAL OCCLUSIONS, RECANALIZATION TECHNIQUES AND OTHER CONSIDERATIONS
SESSION 98:	VENOUS THROMBOSIS SCIENCE AND TREATMENT STRATEGIES
SESSION 99:	THROMBUS REMOVAL THROMBECTOMY DEVICES AND OTHER ISSUES TO CONSIDER
SESSION 100:	PELVIC VEIN DISORDERS
SESSION 101:	MORE VENOUS THROMBOSIS
SESSION 102:	IVC FILTERS AND MORE ISSUES WITH STENTS
SESSION 103:	MORE DEEP VENOUS OBSTRUCTION, VENA CAVA, AND STENTS
SESSION 104:	MORE IMPORTANT DEEP VENOUS CONCEPTS
SESSION 105:	VENOUS REFLUX ISSUES AND DEEP VEIN VALVE TECHNOLOGIES

Saturday, November 23, 2024 - Program Details

Open All Saturday Sessions

6:00 AM - General Registration - New York Hilton Midtown
                 Gramercy Suite East, 2nd Floor
6:00 AM - Faculty Registration - New York Hilton Midtown
                 Gramercy Suite West, 2nd Floor
6:15 AM - Continental Breakfast - New York Hilton Midtown
                 Grand Ballroom Foyer - 3rd Floor

PROGRAMS N, O AND P ARE CONCURRENT SATURDAY PROGRAMS
PROGRAM N (SESSIONS 106-109 - TOPICS TOO IMPORTANT TO MISS IN GENERAL AND IN THE TREATMENT OF LOWER EXTREMITY, AORTIC OR CAROTID DISEASE; 7:00 A.M. to 12:06 P.M.) Location: Grand Ballroom East, 3rd Floor
SESSION 106:	MISCELLANEOUS/GENERAL TOPICS AND LOWER EXTREMITY TOPICS TOO IMPORTANT TO MISS
SESSION 107:	MORE LOWER EXTREMITY TOPICS TOO IMPORTANT TO MISS
SESSION 108:	AORTIC TOPICS TOO IMPORTANT TO MISS AND SPINE EXPOSURE
SESSION 109:	AORTIC AND CAROTID TOPICS TOO IMPORTANT TO MISS
PROGRAM O (SESSIONS 110-115 - IMPROVING OUTCOMES IN HEMODIALYSIS ACCESS; 8:00 A.M. to 4:00 P.M.) Location: Grand Ballroom West, 3rd Floor
SESSION 110:	IMPORTANT ISSUES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
SESSION 111:	MORE IMPORTANT ISSUES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
SESSION 112:	MINISYMPOSIUM: HEMODIALYSIS ACCESS INDUCED DISTAL ISCHEMIA (7-MINUTE TALKS)
SESSION 113:	POLITICAL, ECONOMIC AND LEGAL ISSUES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
SESSION 114:	NOVEL TECHNOLOGIES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
SESSION 115:	UPDATE ON CLINICAL CHALLENGES IN HEMODIALYSIS ACCESS (7-MINUTE TALKS)
COMBINED VEITHsymposium and AVIDsymposium SESSIONS
VEITHsymposium PROGRAM P (SESSIONS 116-125 - ADVANCES IN VASCULAR IMAGING AND DIAGNOSIS; 7:00 A.M. to 5:10 P.M.) Location: Murray Hill Suites, 2nd Floor
SESSION 116:	MANAGING THE PATIENT WITH PERIPHERAL ARTERIAL OCCLUSIVE DISEASE (PAD): STRENGTHS AND WEAKNESSES OF THE DIAGNOSTIC TECHNIQUES, WHO NEEDS WHICH TESTS AND WHEN
SESSION 117:	ABDOMINAL IMAGING TIPS AND TRICKS: LESSONS LEARNED FROM CASE STUDY PRESENTATIONS
SESSION 118:	CEREBROVASCULAR
SESSION 119:	PRACTICE ENHANCEMENTS AND PHILOSOPHICAL ISSUES I
SESSION 120:	TECHNICAL SKILLS LAB
SESSION 121:	INTERPRETING WITH THE MASTERS
SESSION 122:	WHAT THE VASCULAR SPECIALIST SHOULD EXPECT FROM A WELL-DONE VASCULAR ULTRASOUND EVALUATION
SESSION 123:	VENOUS IMAGING: TESTING FOR CHRONIC VENOUS INSUFFICIENCY, LEG REFLUX AND PELVIC VEIN DISORDERS
SESSION 124:	THE EVOLVING HEALTHCARE ENVIRONMENT: IMPACT ON PAYMENT, POLICY, LAB MANAGEMENT AND SVU UPDATES
SESSION 125:	HEMODIALYSIS ACCESS, CURVEBALLS AND CONTROVERSIES